Bioscience Co. Ltd. on May 30 gained Chinese approval of Mailisheng (albipagrastim alfa; 8MW-0511) as a subcutaneous injection to treat febrile neutropenia induced by myelosuppressive anticancer ...

An oncology nurse shares advice for avoiding exhaustion and soreness when administering subcutaneous injections.

The FDA has accepted for Priority Review the BLA for sibeprenlimab for the treatment of immunoglobulin A nephropathy in adults.

The US Food and Drug Administration (FDA) has accepted Otsuka Pharmaceutical’s biologics licence application for ...

Vyvgart for subcutaneous injection is available as a vial or prefilled ... active treatment within the past six months or newly diagnosed) or being treated with immunoglobulin therapy or ...

VYVGART for subcutaneous injection is available as a vial or prefilled ... active treatment within the past six months or newly diagnosed) or being treated with immunoglobulin therapy or ...

The 12–month study involved 233 subjects, including 217 patients under the age of 18. Only 14% of the patients who received subcutaneous injections of immunoglobulin missed work or study due to ...

The approval of subcutaneous immunoglobulin (SCIg) in 2006 further revolutionized ... Whereas SCIg requires more frequent infusions and multiple injection sites, its reduced systemic reactions and ...

"We are very pleased that patients in Japan with agammaglobulinemia or hypogammaglobulinemia can now access HYQVIA, which represents the first and only subcutaneous immunoglobulin therapy that ...

Immune globulin (human) is under clinical development by Grifols ... It is formulated as solution for intramuscular or subcutaneous route of administration. Flebogamma DIF (Double Inactivation and ...

Takeda, is focused on creating better health for people and a brighter future for the world, announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of Hyqvia [Immune ...